EssilorLuxottica S.A. (ESLOY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EssilorLuxottica S.A. (ESLOY) trades at $99.01 with AI Score 49/100 (Grade C). EssilorLuxottica S. A. Market cap: $91.01B, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026ESLOY stock analysis for 2026: Analysts have set a consensus price target of $177.00 for EssilorLuxottica S.A., suggesting 78.8% upside from the current price of $99.01. The AI MoonshotScore is 49/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
ESLOY: the 1 perspectives are evenly split.
How is this calculated? →EssilorLuxottica S.A. (ESLOY) Healthcare & Pipeline Overview
EssilorLuxottica S.A. is a global leader in ophthalmic lenses, frames, and sunglasses, operating across wholesale, retail, and equipment segments. Founded in 1849 and headquartered in Paris, France, the company leverages a vast network of laboratories and brands to serve diverse markets worldwide, focusing on vision care innovation and eyewear fashion.
What Is the Investment Thesis for ESLOY?
EssilorLuxottica S.A. presents a compelling investment profile driven by its global leadership in the diversified eyewear market, robust financial metrics, and strategic positioning. With a substantial market capitalization of $91.01B and a P/E ratio of 22.3, the company demonstrates significant scale and market confidence. Its strong profitability is evidenced by an 8.1% profit margin and an impressive 60.6% gross margin, indicating efficient operations and pricing power within its segments. A free cash flow of $3.15 billion provides financial flexibility for reinvestment and shareholder returns, complemented by a 2.19% dividend yield. The company's low Beta of 0.54 suggests relatively lower volatility compared to the broader market. Key growth catalysts include continued innovation in ophthalmic lens technology, expansion into underserved emerging markets, and the ongoing integration of digital solutions for online sales. The diverse brand portfolio across luxury, sports, and corrective eyewear, coupled with its extensive global distribution network of 490 prescription laboratories and edging-mounting facilities, underpins its value proposition. However, potential risks include intense competition, evolving consumer preferences, and global economic fluctuations. The company's ability to leverage its integrated value chain, from manufacturing to retail, positions it to capture growth in the expanding global vision care market.
Based on FMP financials and quantitative analysis
ESLOY Key Highlights
- Market capitalization of $91.01B, reflecting its significant scale and market presence in the global eyewear industry.
- A P/E ratio of 22.3, indicating investor confidence in its earnings potential relative to its peers.
- Robust gross margin of 60.6%, showcasing strong cost management and pricing power across its diverse product portfolio.
- A profit margin of 8.1%, demonstrating effective operational efficiency in converting revenue into net income.
- Generated $3.15 billion in Free Cash Flow (FCF), providing substantial financial flexibility for strategic investments and shareholder returns.
Who Are ESLOY's Competitors?
ESLOY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SRTOY Sartorius Stedim Biotech S.A. | $20.27 | -2.99% | $197.26B | 51 |
| NONOF Novo Nordisk A/S | $48.95 | -0.26% | $217.48B | 52 |
| SNYNF Sanofi | $85.25 | +0.64% | $102.48B | 48 |
| FSNUY Fresenius SE & Co. KGaA | $12.50 | +3.91% | $112.65B | 43 |
| SOAGY Sartorius AG | $52.23 | -0.08% | $76.31B | 45 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| STXS Stereotaxis, Inc. | $1.88 | +5.03% | $183.74M | 60 |
| IVTY Invuity, Inc. | $7.39 | +0.00% | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ESLOY's Key Strengths?
- Global leadership position in ophthalmic lenses and eyewear with an integrated business model.
- Extensive portfolio of strong, recognized brands across luxury, sports, and corrective eyewear.
- Robust financial performance with high gross margins and significant free cash flow.
- Broad geographic presence across North America, Europe, Latin America, Asia, Oceania, and Africa.
- Strong R&D capabilities driving innovation in lens technology and optical instruments.
What Are ESLOY's Weaknesses?
- Reliance on consumer discretionary spending for luxury and fashion eyewear segments.
- Complexity of managing a vast global supply chain and manufacturing network.
- Potential for brand dilution if portfolio management is not effectively executed.
- Integration challenges stemming from its formation through a merger in 2018.
What Could Drive ESLOY Stock Higher?
- Continued integration synergies from the Essilor-Luxottica merger, potentially leading to enhanced operational efficiencies and cost savings.
- Introduction of new advanced ophthalmic lens technologies and innovative eyewear designs, driving premium product sales and market share gains.
- Expansion of the company's retail footprint and e-commerce capabilities in key growth markets, increasing direct-to-consumer reach.
- Strategic partnerships or acquisitions in the vision care or smart eyewear segments, broadening product offerings and market penetration.
- Growth in demand for luxury and sports eyewear, driven by increasing disposable incomes and evolving fashion trends globally.
What Are the Key Risks for ESLOY?
- Intense competition from other global eyewear manufacturers and emerging direct-to-consumer brands, potentially impacting market share and pricing power.
- Fluctuations in global economic conditions and consumer discretionary spending, which could reduce demand for premium eyewear products.
- Disruptions in the global supply chain, including raw material shortages or increased manufacturing costs, affecting production and profitability.
- Currency exchange rate volatility, particularly between the Euro and other major currencies, impacting reported financial results for ADR holders.
- Regulatory changes in healthcare, product safety, or trade policies across the diverse geographic markets where the company operates.
What Are the Growth Opportunities for ESLOY?
- **Emerging Market Penetration:** EssilorLuxottica has a significant opportunity to expand its presence in emerging markets across Asia, Oceania, and Africa. These regions are characterized by large, growing populations and increasing disposable incomes, which are driving demand for vision care products. While specific market sizes for these regions are unknown, the general trend indicates substantial untapped potential for both corrective lenses and fashionable eyewear. By leveraging its established distribution networks and adapting product offerings to local preferences and affordability, the company can capture a larger share of these developing markets over the long term, enhancing its global revenue streams.
- **Digital Sales and E-commerce Expansion:** The company is actively developing solutions for online sales of optical products, which represents a substantial growth avenue. The global e-commerce market for eyewear is experiencing rapid expansion, driven by consumer convenience and broader access to products. By enhancing its digital platforms and supply chain capabilities for online fulfillment, EssilorLuxottica can capitalize on this trend, reaching a wider customer base and offering personalized shopping experiences. This strategic focus on digital channels is crucial for maintaining competitiveness and driving sales growth in the evolving retail landscape.
- **Advanced Lens Technology Innovation:** Continuous innovation in ophthalmic lens technology, such as Varilux progressive lenses, Crizal antireflective coatings, Transitions photochromic lenses, and Eyezen lenses for digital device users, presents a key growth driver. The demand for specialized vision solutions addressing modern lifestyle needs, like protection from blue light and UV radiation, is consistently increasing. Investing in R&D to introduce next-generation lenses with enhanced features and benefits allows EssilorLuxottica to maintain its premium positioning, attract new customers seeking advanced vision correction, and command higher price points in the competitive lens market.
- **Expansion and Optimization of Retail Network:** EssilorLuxottica's extensive retail segment offers significant opportunities for growth through both expansion and optimization. While the exact market size for new retail locations is unknown, strategic expansion into underserved geographic areas or high-traffic commercial zones can increase market penetration. Furthermore, optimizing the performance of existing retail stores through enhanced customer experience, personalized services, and integration of digital tools can drive higher sales per square foot. This dual approach ensures both broader reach and improved efficiency across its global retail footprint, strengthening its direct-to-consumer channel.
- **Growth in Luxury and Sports Eyewear Segments:** The wholesale and retail segments' focus on luxury and sports eyewear offers a distinct growth opportunity. The global demand for branded, high-quality, and performance-oriented eyewear continues to rise, driven by fashion trends, brand loyalty, and increased participation in sports and outdoor activities. By continuously innovating designs, collaborating with leading fashion houses and sports brands, and effectively marketing its diverse portfolio of brands like Ray-Ban and Oakley, EssilorLuxottica can capitalize on these segments. This allows the company to cater to affluent consumers and athletes, securing a premium market position.
What Opportunities Does ESLOY Have?
- Expansion into underserved emerging markets with growing middle classes and increasing vision care needs.
- Further development and adoption of digital sales channels and e-commerce solutions.
- Continued innovation in smart eyewear and advanced vision correction technologies.
- Strategic acquisitions of smaller, innovative eyewear brands or technology companies.
- Leveraging data analytics to personalize customer experiences and optimize retail operations.
What Threats Does ESLOY Face?
- Intense competition from both established players and new entrants in the eyewear market.
- Changes in consumer preferences and fashion trends impacting demand for specific brands or styles.
- Economic downturns or recessions reducing discretionary spending on premium eyewear.
- Regulatory changes in healthcare or product safety standards across different regions.
- Disruptions in the global supply chain or increases in raw material costs.
What Are ESLOY's Competitive Advantages?
- **Extensive Brand Portfolio:** Ownership and licensing of numerous iconic and well-recognized brands (e.g., Ray-Ban, Oakley, Varilux, Crizal) create strong consumer loyalty and market demand.
- **Integrated Global Operations:** Control over the entire value chain from R&D and manufacturing to wholesale and retail distribution provides significant cost efficiencies and quality control.
- **Advanced R&D and Technology:** Continuous investment in innovative lens technologies (e.g., progressive, photochromic, anti-reflective) offers superior product performance and differentiation.
- **Vast Distribution and Retail Network:** A global network of 490 prescription laboratories and edging-mounting facilities, coupled with an extensive retail presence, ensures broad market reach and accessibility.
- **Economies of Scale:** As a large global player, the company benefits from economies of scale in production, procurement, and marketing, which smaller competitors cannot easily replicate.
What Does ESLOY Do?
EssilorLuxottica Société anonyme, founded in 1849 and headquartered in Paris, France, stands as a prominent global entity in the vision care and eyewear industry. The company designs, manufactures, and distributes a comprehensive range of ophthalmic lenses, frames, and sunglasses across vast geographic regions including North America, Europe, Latin America, Asia, Oceania, and Africa. Its operational structure is segmented into five distinct areas: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment is dedicated to the manufacturing and global distribution of luxury and sports eyewear, catering to a broad network of clients. Concurrently, the Retail segment focuses on the direct sale of luxury and sports eyewear to consumers through its extensive retail footprint. The Lenses and Optical Instruments segment is a cornerstone of the company's offerings, providing advanced ophthalmic lenses such as Varilux progressive lenses, Crizal antireflective solutions, Transitions photochromic lenses, and Eyezen lenses designed for digital device users. This segment also includes Xperio polarized sun lenses and licenses corrective lens brands like Nikon and Kodak. Furthermore, it supplies lens edging and mounting instruments to opticians and prescription laboratories, alongside optometry instruments for various professional and institutional settings. This segment is also actively involved in developing solutions for online optical product sales. The Equipment segment provides specialized digital surfacing and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers, supporting the broader eyewear production ecosystem. Lastly, the Sunglasses and Readers segment offers a wide array of non-prescription sunglasses and reading glasses under numerous proprietary and licensed brands, including Foster Grant, Gargoyles, Magnivision, Reebok, Steve Madden, Disney, Bolon, and Mujosh. With a robust network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica maintains a significant presence throughout the entire value chain of the eyewear market. The company, formerly known as Essilor International Société Anonyme, adopted its current name in October 2018 following a strategic evolution.
What Products and Services Does ESLOY Offer?
- Designs, manufactures, and distributes ophthalmic lenses, including progressive, anti-reflective, photochromic, and digital-specific lenses.
- Produces and wholesales luxury and sports eyewear frames and sunglasses under various proprietary and licensed brands.
- Operates a global retail network for eyewear, selling directly to consumers.
- Provides lens edging and mounting instruments for opticians and prescription laboratories.
- Offers optometry instruments for eye care professionals and institutions.
- Develops solutions for online sales of optical products, expanding its e-commerce capabilities.
- Manufactures digital surfacing and lens coating machines for lens production facilities.
- Distributes non-prescription sunglasses and reading glasses under numerous consumer brands.
How Does ESLOY Make Money?
- **Integrated Value Chain:** Operates across the entire eyewear value chain, from R&D and manufacturing of lenses and frames to wholesale distribution and direct-to-consumer retail.
- **Diverse Product Portfolio:** Generates revenue from a broad range of products, including prescription lenses, luxury and sports frames, sunglasses, reading glasses, and optical instruments.
- **Global Distribution Network:** Utilizes a vast network of 490 prescription laboratories, edging-mounting facilities, and retail stores to reach customers across North America, Europe, Latin America, Asia, Oceania, and Africa.
- **Brand Licensing and Ownership:** Leverages both proprietary brands (e.g., Varilux, Crizal, Ray-Ban, Oakley) and licensed brands (e.g., Nikon, Kodak, Reebok, Disney) to cater to diverse market segments.
What Industry Does ESLOY Operate In?
EssilorLuxottica S.A. operates within the Healthcare sector, specifically the Medical - Instruments & Supplies industry, but with a strong consumer-facing component through its eyewear brands and retail presence. The global eyewear market is characterized by increasing demand driven by an aging global population, rising incidence of vision impairment, increased screen time leading to digital eye strain, and growing disposable incomes in emerging markets. EssilorLuxottica holds a dominant position, leveraging its integrated business model spanning manufacturing, wholesale, and retail. The competitive landscape includes specialized lens manufacturers, frame designers, and large retail chains. The company differentiates itself through extensive R&D in lens technology, a vast portfolio of iconic brands, and a comprehensive global distribution and retail network. Market trends indicate a shift towards premiumization, personalized vision solutions, and the increasing importance of e-commerce, areas where EssilorLuxottica is actively investing.
Who Are ESLOY's Key Customers?
- **Eye Care Professionals:** Opticians, optometrists, and ophthalmologists who purchase lenses, frames, and optical instruments for their practices.
- **Retail Consumers:** Individuals purchasing prescription eyewear, sunglasses, and reading glasses through the company's retail stores or online platforms.
- **Wholesale Partners:** Independent optical stores, department stores, and other retailers that stock EssilorLuxottica's branded frames and sunglasses.
- **Prescription Laboratories and Lens Manufacturers:** Businesses that acquire digital surfacing and lens coating machines for their production processes.
- **Institutions:** Schools, occupational medicine centers, and military organizations that utilize optometry instruments.
How EssilorLuxottica S.A. Is Valued
EssilorLuxottica S.A. carries a market capitalization of $91.01B, placing it in the large-cap category. Relative to its peer group, ESLOY's quantitative score of 49/100 is roughly in line with the peer average of 48/100.
ROE 6%Key Financial Metrics
Return on equity for EssilorLuxottica S.A. stands at 6.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.6%, showing how much profit it generates from its asset base. ESLOY trades at a trailing price-to-earnings ratio of 22.29, roughly in line with the Healthcare sector average of ~23x. Its free cash flow yield is 5.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.99 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
EssilorLuxottica S.A.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.41 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project EssilorLuxottica S.A. revenue of about $29.69B for fiscal 2026, with EPS near $3.51. The estimate reflects 11 contributing analysts.
ESLOY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Global leadership position in ophthalmic lenses and eyewear with an integrated business model.
- Extensive portfolio of strong, recognized brands across luxury, sports, and corrective eyewear.
- Robust financial performance with high gross margins and significant free cash flow.
- Broad geographic presence across North America, Europe, Latin America, Asia, Oceania, and Africa.
Bear Case
- Reliance on consumer discretionary spending for luxury and fashion eyewear segments.
- Complexity of managing a vast global supply chain and manufacturing network.
- Potential for brand dilution if portfolio management is not effectively executed.
- Integration challenges stemming from its formation through a merger in 2018.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
ESLOY Latest News
-
Reported Earlier: Meta Announces Partneriship With EssilorLuxottica To Launch Meta Glasses
benzinga · Jun 23, 2026
-
Real-life ‘Succession' rocks Ray-Ban dynasty as heir launches $11.5 billion bid to buy out siblings
nypost.com · Jun 22, 2026
-
A Growing Supply Gap Has Analysts Eyeing Applied Materials (AMAT)
Yahoo! Finance: ESLOY News · Jun 22, 2026
-
Applied Materials (AMAT) and EssilorLuxottica Sign Long-Term Deal, Reuters Reports
Yahoo! Finance: ESLOY News · Jun 22, 2026
ESLOY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ESLOY.
Price Targets
Consensus target: $177.00
ESLOY MoonshotScore
What does this score mean?
The MoonshotScore rates ESLOY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Reported Earlier: Meta Announces Partneriship With EssilorLuxottica To Launch Meta Glasses
Real-life ‘Succession' rocks Ray-Ban dynasty as heir launches $11.5 billion bid to buy out siblings
A Growing Supply Gap Has Analysts Eyeing Applied Materials (AMAT)
Applied Materials (AMAT) and EssilorLuxottica Sign Long-Term Deal, Reuters Reports
Leadership: Francesco Milleri
CEO
Francesco Milleri serves as the CEO of EssilorLuxottica S.A., overseeing a global workforce of 153,498 employees. His career trajectory has been marked by significant leadership roles within the Luxottica Group prior to the merger with Essilor. Milleri's background is rooted in strategic management and corporate governance, having been a close associate and strategic advisor to Leonardo Del Vecchio, the founder of Luxottica. This long-standing relationship provided him with deep insights into the eyewear industry's intricacies, brand management, and global operational strategies. His expertise spans across various facets of the business, from product development and manufacturing to retail distribution and market expansion.
Track Record: Under Francesco Milleri's leadership, EssilorLuxottica has focused on integrating the vast operations of Essilor and Luxottica, aiming to unlock synergies and enhance market efficiency. He has been instrumental in driving the company's strategy for digital transformation, emphasizing the expansion of online sales channels and leveraging technology for improved customer engagement. His tenure has seen a continued commitment to innovation in lens technology and the strategic management of the company's extensive brand portfolio, aiming to solidify its global market leadership and operational excellence.
EssilorLuxottica S.A. ADR Information Unsponsored
EssilorLuxottica S.A. trades as an American Depositary Receipt (ADR) on the OTC market under the ticker ESLOY. An ADR is a certificate issued by a U.S. depositary bank that represents a specified number of shares of a foreign company's stock. For ESLOY, this means U.S. investors can buy and sell shares of EssilorLuxottica S.A. in U.S. dollars without directly trading on the Paris stock exchange, simplifying cross-border investment and settlement processes.
- Home Market Ticker: Euronext Paris, France
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: ESLO
ESLOY OTC Market Information
ESLOY trades on the OTC (Over-The-Counter) market, specifically categorized as 'OTC Other.' This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or that choose not to provide financial information to OTC Markets Group. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which have stringent listing requirements and regulatory oversight by the SEC, OTC stocks operate in a less regulated environment. The 'OTC Other' designation implies that the company's disclosure status is unknown, which can present challenges for investors seeking comprehensive and timely financial information.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity and wider bid-ask spreads compared to exchange-listed stocks, potentially impacting trade execution.
- Unknown disclosure status, which may limit access to timely and comprehensive financial information.
- Less stringent regulatory oversight by the SEC compared to major exchanges, increasing potential for information asymmetry.
- Greater price volatility due to lower trading volumes and fewer institutional investors.
- Difficulty in obtaining reliable price quotes and market data compared to exchange-listed securities.
- Verify the company's financial statements and annual reports directly from its official website or home country regulatory filings (e.g., AMF in France).
- Research the company's corporate governance structure and management team beyond what is available on OTC Markets.
- Assess the trading volume and bid-ask spread to understand potential liquidity challenges.
- Evaluate the company's business fundamentals, competitive landscape, and growth prospects independently.
- Consult with a financial advisor experienced in international and OTC investments.
- Understand the specific risks associated with Level 1 ADRs, including currency and tax implications.
- Monitor news and developments from the company's home market for material information.
- The company is a well-established global leader in its industry, founded in 1849 and headquartered in Paris, France.
- It has a significant market capitalization of $91.01B, indicating a substantial and recognized enterprise.
- EssilorLuxottica S.A. is an American Depositary Receipt (ADR) of a publicly traded company on Euronext Paris (ESLO), its primary stock exchange.
- Its operations span multiple continents with a vast network of facilities and a diverse brand portfolio, signifying a robust operational presence.
- The company reports financial performance with metrics like profit margin (8.1%) and free cash flow ($3.15B), suggesting active financial reporting in its home market.
Common Questions About ESLOY (Healthcare)
What does EssilorLuxottica S.A. do?
EssilorLuxottica S.A. is a global leader in the design, manufacture, and distribution of a comprehensive range of ophthalmic lenses, frames, and sunglasses. The company operates through five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. It offers advanced corrective lenses like Varilux and Crizal, iconic eyewear brands such as Ray-Ban and Oakley, and provides optical instruments and manufacturing equipment. With a vast global network of 490 prescription laboratories and retail stores, EssilorLuxottica serves diverse markets across North America, Europe, Latin America, Asia, Oceania, and Africa, addressing both vision correction and fashion eyewear needs.
How does EssilorLuxottica S.A. maintain its market leadership in the global eyewear industry?
EssilorLuxottica maintains its market leadership through a highly integrated business model that spans the entire eyewear value chain, from research and development to manufacturing, wholesale distribution, and direct-to-consumer retail. This integration provides significant control over product quality, supply chain efficiency, and market reach. The company also boasts an unparalleled portfolio of strong, globally recognized brands, including both proprietary lens technologies (e.g., Varilux, Transitions) and iconic frame brands (e.g., Ray-Ban, Oakley). Continuous investment in R&D for advanced lens technologies and a vast global distribution network further solidify its competitive advantage, making it challenging for competitors to replicate its scale and breadth of offerings.
What are the key growth opportunities for ESLOY in the evolving vision care market?
EssilorLuxottica S.A. has several significant growth opportunities in the evolving vision care market. One key area is the continued expansion into emerging markets, particularly in Asia, Oceania, and Africa, where rising disposable incomes and increasing awareness of vision health are driving demand. Another opportunity lies in the further development and integration of digital sales channels and e-commerce solutions, capitalizing on the growing consumer preference for online shopping. Additionally, ongoing innovation in advanced lens technologies, such as those addressing digital eye strain or offering enhanced photochromic properties, allows the company to capture premium market segments. The growing demand for luxury and sports eyewear also presents a sustained growth avenue, leveraging its strong brand portfolio.
What are the primary risks associated with investing in EssilorLuxottica S.A. (ESLOY) on the OTC market?
Investing in EssilorLuxottica S.A. (ESLOY) on the OTC market carries several specific risks. As an 'OTC Other' stock, its disclosure status is unknown, meaning investors may face challenges accessing timely and comprehensive financial information directly through OTC Markets Group. This tier also typically implies lower liquidity and wider bid-ask spreads compared to exchange-listed stocks, which can make it difficult to buy or sell shares efficiently without impacting the price. Furthermore, as a Level 1 ADR, ESLOY is subject to currency risk due to fluctuations between the Euro and the U.S. Dollar, affecting both the investment's capital value and dividend payouts. Less stringent regulatory oversight on the OTC market compared to major exchanges also poses a risk of information asymmetry.
What are the key factors to evaluate for ESLOY?
EssilorLuxottica S.A. (ESLOY) holds an AI score of 49/100 (low). P/E: 22.3x vs the S&P 500's ~20-25x. Analysts target $177.00 (+79%). Not financial advice.
How frequently does ESLOY data refresh on this page?
ESLOY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ESLOY's recent stock price performance?
EssilorLuxottica S.A. (ESLOY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global leadership position in ophthalmic lenses and eyewear with an integrated business model. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ESLOY overvalued or undervalued right now?
EssilorLuxottica S.A. (ESLOY) trades at 22.3x earnings. Analysts target $177.00 (+79%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.